Glass House Brands Inc. (GLAS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$73.94M
As of 2025-12-31
-24.1%
3-year compound annual growth
+23.0%
5-year compound annual growth
$182.13M2020-12-31: $26.27M2021-12-31: $182.13M2022-12-31: $168.86M2023-12-31: $89.76M2024-12-31: $116.24M2025-12-31: $73.94M$73.94M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$73.94M-36.4%2026-03-24, Balance as of period end
2024-12-31$116.24M+29.5%2026-03-24, Balance as of period end
2023-12-31$89.76M-46.8%2025-03-25, Balance as of period end
2022-12-31$168.86M-7.3%2024-04-02, Balance as of period end
2021-12-31$182.13M+593.2%2024-04-02, Balance as of period end
2020-12-31$26.27Mn/a2022-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Glass House Brands Inc. (GLAS)2025-12-31$73.94M-36.4%
biote Corp. (BTMD)2025-12-31-$58.54Mn/m
Marimed Inc. (MRMD)2025-12-31$50.01M-14.6%
Cronos Group Inc. (CRON)2025-12-31$1.14B+2.9%
Natural Alternatives International Inc (NAII)2026-06-30$49.96M-27.0%
Niagen Bioscience, Inc. (NAGE)2025-12-31$76.53M+66.0%
Jushi Holdings Inc. (JUSH)2025-12-31-$115.34Mn/m
Mannatech Inc (MTEX)2025-12-31-$5.22Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$43.64M+20.8%

Compare GLAS, BTMD, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗